|
|
||||||||
J Biol Chem, Vol. 275, Issue 9, 6207-6213, March 3, 2000
From the Department of Biochemistry, Stockholm University,
S-10691 Stockholm, Sweden
We have studied the membrane insertion of ProW,
an Escherichia coli inner membrane protein with seven
transmembrane segments and a large periplasmic N-terminal tail, into
endoplasmic reticulum (ER)-derived dog pancreas microsomes. Strikingly,
significant levels of N-tail translocation is seen only when a minimum
of four of the transmembrane segments are present; for constructs with
fewer transmembrane segments, the N-tail remains mostly nontranslocated and the majority of the molecules adopt an "inverted" topology where normally nontranslocated parts are translocated and vice versa.
N-tail translocation can also be promoted by shortening of the N-tail
and by the addition of positively charged residues immediately
downstream of the first trasnmembrane segment. We conclude that as many
as four consecutive transmembrane segments may be collectively involved
in determining membrane protein topology in the ER and that the effects
of downstream sequence determinants may vary depending on the size and
charge of the N-tail. We also provide evidence to suggest that the ProW
N-tail is translocated across the ER membrane in a C-to-N-terminal direction.
The structure and function of integral membrane proteins are in
part determined by their topology, i.e. the orientation
(Ncyt or Nexo) of each transmembrane segment
(TM)1 relative to the
membrane. Two general mechanisms for the membrane assembly of a
polytopic membrane protein have been proposed. In the first, the
overall topology is assumed to be determined by the most N-terminal TM,
with downstream TMs serving alternately as stop transfer and signal
anchor sequences (1). The second model suggests that topogenic
information is spread throughout the protein and that downstream TMs
may affect the orientation of upstream ones (2-4).
One aspect of membrane protein assembly that is not fully understood is
the translocation of N-terminal tails (N-tails) across the membrane
(5). N-tail translocation is presumably initiated by a hydrophobic
"reverse signal-anchor" sequence that also becomes the first TM
segment (6-10). In eukaryotic cells, N-tail translocation has been
shown to proceed by the normal signal recognition particle-Sec61 pathway (11) and to require an unfolded N-terminal domain (12). In
contrast, N-tail translocation in Escherichia coli appears to be possible both by a SecA-dependent (10) and by a
Sec-independent mechanism (6-8, 13), depending on the protein. In both
prokaryotic and eukaryotic cells, it seems that the presence of too
many positively charged amino acids can prevent N-tail translocation,
whereas negatively charged residues may facilitate translocation (6, 7,
14-17).
The 100-residue-long periplasmic N-terminal domain of the E. coli inner membrane protein ProW (6, 18) is one of the longest known N-tails. Earlier studies in E. coli have shown that
the ProW N-tail can be efficiently translocated across the inner
membrane (6, 7). We have now expressed ProW in vitro in the
presence of ER-derived dog pancreas microsomes and have studied N-tail translocation in the full-length protein as well as in fusion constructs lacking one or more TM segments and with N-tails of different lengths. Strikingly, and in contrast to previous findings in
E. coli, we find that a minimum of four TM segments must be present to reach appreciable levels of N-tail translocation; constructs with up to three TM segments mainly adopt an "inverted" topology with the N-tail in the cytoplasm. Shortening of the N-tail increases translocation efficiency and reduces the number of TMs that need to be
present for N-tail translocation to occur.
The full-length ProW N-tail is efficiently translocated across the ER
membrane when fused to the N terminus of another E. coli
inner membrane protein, leader peptidase (Lep). Studies of the kinetics
of glycosylation of Asn-Xaa-Thr acceptor sites located either early or
late in the N-tail in this construct strongly suggest that N-tail
translocation proceeds in a C-to-N-terminal direction.
These observations show that the whole TM1-TM4 region of ProW can
influence N-tail translocation across the ER membrane. Thus, distant
downstream sequence determinants can affect the insertion of the most
N-terminal parts of a polytopic membrane protein into the ER membrane.
Enzymes and Chemicals--
Unless otherwise stated, all enzymes
as well as plasmid pGEM1, RiboMAX SP6 RNA polymerase system, and rabbit
reticulocyte lysate were from Promega (Madison, WI) or New England
Biolabs (Boston, MA). T7 DNA polymerase, Taq polymerase,
[35S]Met and 14C-methylated marker proteins,
ribonucleotides, deoxyribonucleotides, dideoxyribonucleotides, and the
cap analog m7G(5')ppp(5')G were from Amersham Pharmacia Biotech.
Aurintricarboxylic acid was from Sigma. Qiagen PCR purification kit and
Qiagen RNeasy RNA clean up were from Qiagen (Hilden, Germany).
Oligonucleotides were from Kebo Lab and Cybergene (Stockholm, Sweden).
DNA Techniques--
Site-specific mutagenesis was performed
according to the method of Kunkel (19, 20) or by PCR. All mutants were
confirmed by sequencing of plasmid DNA. PCR was used to amplify
fragments from pING1 (21) and pGEM1 plasmids containing the desired DNA constructs. The amplified DNA products were purified using Qiagen PCR
purification kit as described in the manufacturer's protocol. All
cloning steps were done according to standard procedures.
Construction of Full-length and Truncated ProW Glycosylation
Mutants--
The gene coding for E. coli ProW was amplified
by PCR from genomic DNA using 5'- and 3'-specific oligonucleotides
containing N- or C-terminal glycosylation sites (see below) and
suitable restriction sites for cloning into pGEM1. The full-length ProW construct containing an N-terminal glycosylation site was engineered using a 5'-specific oligonucleotide, which introduced a mutation encoding the N-glycosylation site
Asn5-Asn6-Thr7 near the N terminus
of ProW, a Kozak consensus sequence (22) for enhanced translation, and
a XbaI site for cloning (modified nucleotides underlined):
...
ACCTCTAGAGCCACCATGGCTGATCAAAATAATACGTGGGATACCACGCCAGCG. . . . .
The reverse oligonucleotide encoded the 3' end of ProW, a stop codon,
and a SmaI site for cloning. Truncated ProW molecules were
made in the same way, but with the reverse 3' oligonucleotide (including stop codons) hybridizing to the relevant internal portions of the proW gene.
The C-terminal C* reporter domain was introduced by a two-step PCR
amplification. In the first step a common 5'-specific primer and
individual 3'-primers specific for the full-length gene and the various
truncations, were used. The common 5'-specific primer was identical to
the one described above except that it lacked the glycosylation
acceptor site. The individual 3'-oligonucleotides introduced a
C-terminal Asn-Leu-Thr glycosylation site located at least 16 amino
acid residues downstream of the nearest transmembrane domain. To
increase the glycosylation efficiency of the C* reporter, a second PCR
amplification was done using the same common 5'-specific primer
described above and a common 3'-specific primer introducing a
C-terminal extension of 18 amino acid residues downstream of the
Asn-Leu-Thr site followed by a SmaI restriction site for
cloning into pGEM1. The encoded sequence of the spacer behind the
glycosylation site was SGKENGIRLSERKETLGD. The PCR products were cloned
into XbaI-SmaI-restricted pGEM1 plasmids.
Construction of ProW/P2 and ProW/P2' Fusions--
The
construction of ProW/P2 fusions in pING1 containing up to three
transmembrane segments was described previously (23). Cloning into
pGEM1 was done using ProW/P2 XbaI-SmaI fragments that were amplified from the corresponding pING1 constructs using a
universal 5'-specific primer containing an XbaI site and a
Kozak consensus sequence (see above) and individual 3'-specific primers containing a SmaI site. For the construction of ProW/P2
fusions containing four to seven transmembrane segments, the
appropriate fragments amplified by PCR from the genomic copy of ProW
were cloned into a XbaI-KpnI-restricted pGEM1
ProW(TM1-3)/P2 plasmid. The ProW/P2' fusions were constructed in a
similar way, except that the 3' primer introduced a stop codon in
position 216 in Lep (this removes the naturally occurring glycosylation
site at Asn214), together with a SacI
restriction site. Site-specific mutagenesis was used to introduce three
Arg residues between positions 119 and 120 in the ProW TM1-2 loop. The
three Arg mutants were cloned into pGEM1 as an
XbaI-SmaI fragment.
Shortening of the N-tail in ProW/P2 and ProW/P2'
Fusions--
mRNAs encoding constructs with shortened ProW N-tails
were prepared using PCR to amplify fragments from the relevant
pGEM1 plasmids.2 The 5'
primers all had the common sequence
5'-GATTTAGGTGACACTATAGAGGAAACAGGACCATGGCCAATTCCACC. . . . .
.-3' and contained the SP6 transcriptional promoter, a ribosome-binding site, an initiator codon, and a Asn-Ser-Thr
glycosylation site (underlined). The unique sequence at the 3' end was
designed to hybridize at the position of the first residue after the
intended deletion in the N-tail. Constructs with ProW residues 1-30,
1-50, and 1-70 deleted were made (note that the PCR primer adds 5 residues to the N terminus of the deletion constructs). The 3' primers were chosen to have a stop codon in position 216 or 324 in Lep as
detailed above.
Construction of ProW N-tail-Lep Fusions--
Nt/Lep fusions were
constructed by PCR amplification of relevant fragments of the
proW and lep genes to create in-frame fusions with Lep residues 1-323 or 1-215. The fusion joint in the Nt/Lep fusion proteins was -QQ99 TRM1A- (numbers refer
to the wild-type ProW and Lep sequences). The ProW N-tail was amplified
using a 5' primer situated 210 bases upstream of the translation start
and a 3' primer at position 99 in ProW containing a SpeI
site. The 5' primer for the amplification of Lep contained a
XbaI site and the 3' primer had a stop codon in positions
216 or 324. The cleaved PCR fragments were purified on agarose gel and
were ligated directly in the gel. Templates for in vitro
transcription of mRNA were prepared using PCR to amplify the
ligated fragments using the same SP6 promoter-containing 5' primer and
the same 3' primers with stop codons at either position 216 or 324 in
Lep as above. In construct *Nt(Asn80)/Lep-P2', the
glycosylation acceptor site in the ProW N-tail had the sequence
Asn80-Ser-Thr.
In Vitro Transcription--
Templates for in vitro
transcription were prepared as described in Ref. 24 or by PCR
amplification with the pGEM1 constructs as template. The 5' primer was
the same in all cases and had the sequence 5'-TTCGTCCAACCAAACCGACTC-3'
(except when the SP6 promoter-containing primers were used; see above).
This primer is situated 210 bases upstream of the translational start,
and the amplified fragments thus contained the SP6 transcriptional
promoter from pGEM1. The 3' primers contained stop codons in the
appropriate positions. Amplified PCR fragments were transcribed from
the SP6 promoter using the Large Scale RNA Synthesis kit with the
RiboMAX SP6 RNA polymerase system. Transcriptions were carried out at
30 °C for 12 h. The mRNAs were purified using Qiagen RNeasy
clean up kit and verified on a 1% agarose gel.
In Vitro Translation--
Translation in reticulocyte lysate in
the presence of dog pancreas microsomes was performed as described in
Ref. 24. Sodium carbonate extraction of microsomes was carried out as
described in Ref. 25. Proteins were analyzed by SDS-polyacrylamide gel electrophoresis, and gels were quantitated on a Fuji BAS1000
phosphoimager using the MacBAS 2.31 software. The extent of
glycosylation of a given mutant was calculated as the quotient between
the intensity of the glycosylated band divided by the summed
intensities of the glycosylated and nonglycosylated bands. In general,
the glycosylation efficiency varied by no more than ± 5% between
repeat experiments. Kinetics of glycosylation was measured as described
in Ref. 26, and the results were quantitated by phosphoimager analysis.
To study N-tail translocation in the ProW protein in a
microsome-supplemented in vitro translation system, we
engineered series of ProW fusion proteins and truncated ProW variants
containing unique N- or C-terminal N-glycosylation acceptor Asn-Xaa-Thr
sites. In most constructs, the N-terminal glycosylation site was placed at residues 5-7 in the ProW N-tail by mutating these residues to
Asn-Asn-Thr. As C-terminal reporters we used both the P2-domain (residues 81-323) from the E. coli inner membrane protein
Lep and a short C-terminal tag (C*) including an Asn-Leu-Thr
glycosylation acceptor site followed by an 18-residue-long tail (see
"Materials and Methods"). The P2 reporter has a naturally occurring
glycosylation site (Asn214-Glu-Thr) and is well suited for
topological mappings based on N-linked glycosylation (27,
28). A truncated version of the P2 domain, P2' (residues 81-215),
lacking the glycosylation site was also used. All constructs were
expressed in vitro in the absence or presence of dog
pancreas rough microsomes. Because N-linked glycosylation
occurs only in the lumen of the microsomes, the localization of the
introduced acceptor sites can be determined by assaying their
glycosylation status. Addition of a single N-linked oligosaccharide to the nascent chain leads to an increase in molecular mass of about 2 kDa that is easily detectable by SDS-polyacrylamide gel electrophoresis.
Topology of Full-length ProW in Microsomes--
The topology of
ProW in the inner membrane of E. coli has previously been
determined by PhoA/LacZ fusion analysis and protease mapping (6, 18).
As shown in Fig. 1, the protein has seven TM segments, and the long N-tail is located in the periplasm. The
topology of full-length ProW in microsomes was probed by (i) introducing a glycosylation acceptor site in positions 5-7 in the
N-tail, (ii) constructing a full-length ProW/P2* fusion, and (iii)
adding a short C-terminal extension (C*) containing a glycosylation acceptor site to the full-length protein. In what follows, an asterisk
always indicates the presence of an Asn-Xaa-Thr glycosylation acceptor
site in the relevant domain.
As shown in Fig. 2, ~30% of the
molecules with the N-terminal acceptor site were glycosylated when
expressed in vitro in the presence of microsomes, whereas
essentially no glycosylation was seen for the two C-terminal reporters.
Because the maximal glycosylation efficiency routinely obtained in our
in vitro system is ~80% (see, e.g. construct
TM1/P2* in Fig. 3A and
construct *TM1-3(3R)/P2' in Fig. 5A), we conclude that the
N-tail is translocated into the lumen of the microsomes in ~40% of
the molecules and that the ProW C terminus is on the cytoplasmic side
of the membrane.
Topology of Truncated ProW Constructs--
To map the topology of
ProW in more detail, we constructed fusions where the reporter domains
(the P2* and P2' domains and the C* tag) were fused at various
locations in ProW (Fig. 1).
The results for fusions to the P2* domain are summarized in Fig.
3A (black bars). Unexpectedly, the P2* fusions
after TM1 and TM3 were efficiently glycosylated, whereas the fusion
after TM2 was not glycosylated. On the other hand, and in agreement with the topology determined in E. coli, the fusions after
TM4 and TM6 were more efficiently glycosylated than those after TM5 and
TM7. These observations suggest that the TM1-3 part of ProW, when
expressed without the downstream TM segments, inserts with an inverted
topology compared with that adopted by the full-length molecules. In
contrast, the majority of the molecules in the longer ProW/P2* fusions
have the same C-terminal orientation as in E. coli.
To check whether the length of the C-terminal fusion domain could
affect the topology, fusions to the short C* tag were also analyzed
(Fig. 3A, white bars). In general, glycosylation
levels were lower in this case; this was expected, because
glycosylation acceptor sites located close to the C terminus of a
protein are less efficiently modified than internal sites
(29).3 The results for the C*
fusions paralleled those of the P2* fusions, except for construct
TM1/C*, which was poorly glycosylated. Possibly, because
co-translational targeting may not be possible in this construct where
the TM1 segment is still mostly inside the ribosome at the time of
chain termination, the protein is only inefficiently targeted to the
microsomes. In general, however, the qualitative picture is the same
for the ProW/P2* and ProW/C* fusions, suggesting that the length of the
C-terminal reporter domain has little influence on the topology.
To rule out the possibility that lack of glycosylation was a
consequence of lack of membrane insertion of the protein, we checked
the membrane insertion of the TM1-2/P2* and TM1-3/P2* constructs by
carbonate extraction (30) (Fig. 3B). Both constructs were
quantitatively retained in the alkali-extracted membrane pellet,
demonstrating proper assembly into the microsomal membrane.
Because the C-terminal fusions suggested that the topology may be
different for proteins with up to three TM domains and those with four
or more, we also assayed N-tail translocation in these constructs. To
this end, we expressed *ProW/P2' fusions and truncated *ProW molecules
with a unique glycosylation acceptor site in the N-tail (Fig.
3C). Little glycosylation of the N-tail was seen for the
*TM1/P2', *TM1-2/P2', and *TM1-3/P2' constructs, whereas the
*TM1-4/P2', *TM1-5/P2', *TM1-6/P2', and *TM1-7/P2' constructs were
glycosylated to between 20 and 30% (black bars). Similar results were seen with the truncated ProW molecules (white
bars), except that the *TM1-4 construct was very inefficiently
glycosylated. Thus, N-tail translocation increases significantly when
at least four (P2' fusions) or five (truncated ProW molecules) TM
segments are present. The length of the C-terminal tail thus makes
little difference, except for the *TM1-4 constructs.
We conclude that only a very minor fraction of the ProW/P2 constructs
with up to three TM segments is oriented with the N-tail in the lumen,
whereas a significant fraction (30-40%) of those with four or more TM
segments has a lumenal N-tail. The efficiency of N-tail translocation
in the TM1-4 constructs apparently depends on the length of the
C-terminal tail, with a longer C-tail favoring a lumenal orientation of
the N-tail.
Addition of Positively Charged Residues in the TM1-TM2 Loop Affects
the Topology of the TM1-2/P2 and TM1-3/P2 Constructs--
The TM1-2
loop lacks positively charged residues (Fig. 1), which may contribute
to the unexpected topology of the shorter ProW constructs. To test this
notion, three positively charged arginine residues were inserted
between positions 119 and 120 in the TM1-TM2 loop, and the topology of
the resulting TM1-2(3R) and TM1-3(3R) P2* and P2' fusions was probed
by the glycosylation status of unique N-terminal and C-terminal
acceptor sites (Fig. 4A). The
N-tail was still poorly glycosylated in both the *TM1-2(3R)/P2' and
*TM1-3(3R)/P2' constructs. In contrast, the P2-domain was more
efficiently glycosylated in the TM1-2(3R)/P2* construct than in the
parent TM1-2/P2* construct (34% versus 10%;
cf. Fig. 3A), while the TM1-3(3R)/P2* construct
was much less efficiently glycosylated than its parent (7%
versus 60%). To rule out the possibility that the position
of the glycosylation site in the N-tail affected these results, we
introduced a second acceptor site in position 80, i.e. 20 residues upstream of TM1. The two resulting constructs, **TM1-3/P2'
and **TM1-3(3R)/P2', were as poorly glycosylated as the parent
constructs (data not shown). We also introduced six consecutive
arginines in the TM1-TM2 loop; again, no N-tail translocation was seen
for the resulting *TM1-3(6R)/P2' construct (data not shown). Thus,
although the introduction of positively charged residues in the TM1-TM2
loop leads to its retention in the cytoplasm (and translocation of the
TM2-TM3 loop to the lumen), it does not promote translocation of the
N-tail (Fig. 4B).
Shortening of the N-tail Increases Translocation
Efficiency--
To study the effect of the length of the N-tail on its
translocation, we deleted 24, 45, and 65 N-terminal amino acid residues in the *TM1/P2', *TM1-2/P2', *TM1-3/P2', and *TM1-3(3R)/P2' fusions (Fig. 5A). In all cases, a
unique Asn3-Ser4-Thr5 glycosylation
site was present in the N-tail. Little increase in N-tail glycosylation
was seen for the shorter *TM1/P2' and *TM1-2/P2' constructs. In
contrast, shortening of the N-tail in the *TM1-3/P2' construct led to
an appreciable increase in glycosylation efficiency. For the
*TM1-3(3R)/P2' construct, essentially complete N-tail translocation
(i.e. ~80% modification) was observed when the N-tail was
shorter than ~50 residues.
N-tail translocation also became markedly more efficient in the
*TM1-3/P2', *TM1-4/P2', *TM1-5/P2', *TM1-6/P2', and *TM1-7/P2' constructs when the N-tail was shortened to 30 residues (Fig. 5B; see also black bars in Fig. 3C),
and similar results were obtained with the corresponding C-terminally
truncated constructs (white bars; note that the
*TM1(
Thus, N-tail translocation can be promoted by shortening the N-tail,
and can be further increased by the addition of positively charged
residues to the TM1-2 loop. Again, for a given length of the N-tail,
we observe more efficient N-tail translocation as the number of TM
segments is increased. Interestingly, the short N-tail in the
*ProW( Efficient N-tail Translocation by Replacement of the ProW TM
Domain--
Because the efficiency of N-tail translocation was found
to depend mainly on the number of transmembrane segments, it was also
of interest to check whether the identity of the transmembrane domain
would affect the translocation efficiency. We thus constructed fusions
between the ProW N-tail (residues 1-99) and Lep residues 1-215
(*Nt/Lep-P2') or the full-length Lep protein (Nt/Lep-P2*). Lep has two
transmembrane segments (residues 4-22 and 62-76), and both the N and
C terminus face the lumen when Lep is integrated into microsomes (31,
32) (Fig. 6A). As shown in
Fig. 6B, the ProW N-tail was quite efficiently translocated
in this context (59% glycosylation of *Nt/Lep-P2'), despite the fact
that only two TM segments are present, and the P2 domain was likewise
translocated into the lumen as seen from the efficient glycosylation
(62%) of Nt/Lep-P2*.
Kinetics of N-tail Glycosylation in Nt/Lep-P2' Suggests That the
N-tail Is Translocated in a C-to-N-terminal Direction--
The rather
efficient translocation of the full-length ProW N-tail in the
*Nt/Lep-P2' construct made it possible to study the direction of N-tail
translocation. To this end, glycosylation acceptor sites were
introduced in position 5 or 80 near the N-terminal and C-terminal ends
of the N-tail, respectively (Fig. 6A). Synchronized translation was initiated by the addition of mRNA to the
translation mix, and further chain initiation was blocked after 1.5 min
by addition of the inhibitor aurintricarboxylic acid. The kinetics of
glycosylation of the two sites was then followed as initially described
by Rothman and Lodish (33), i.e. by dissolving the microsomes by addition of the detergent Triton X-100 at different time
points (thus preventing further glycosylation) and then allowing translation to go to completion. Results for the
*Nt(Asn5)/Lep-P2' and *Nt(Asn80)/Lep-P2'
constructs are shown in Fig.
7A. To rule out that the glycosylated forms of the two constructs represent different
populations of molecules, the analysis was carried out also for
construct **Nt(Asn5, Asn80)/Lep-P2' containing
both sites.
As is clear from the quantitations in Fig. 7B, glycosylation
of the *Nt(Asn80)/Lep-P2' construct preceded that of the
*Nt(Asn5)/Lep-P2' construct by about 3 min. Glycosylation
of the Asn80 site was first detected about 7 min after
initiation of translation. Separate measurement of the overall
translation rate of the two constructs in the in vitro
system yielded a value of 0.4 amino acids/s (data not shown). Assuming
a uniform translation rate, the nascent chain is thus roughly 170 residues long after 7 min. Because approximately 70 residues are
required to span the distance between the ribosomal P-site and the
oligosaccharyl transferase active site (34), glycosylation of
Asn80 happens at about the time expected if translocation
is initiated by TM1, whereas Asn5 is glycosylated ~3 min
later. Glycosylation of the **Nt(Asn5,
Asn80)/Lep-P2' construct proceeded in two steps separated
by about 3 min, and the final glycosylation levels were 53% doubly
glycosylated molecules and 14% singly glycosylated molecules (data not
shown), consistent with the results for the single acceptor site mutants.
These results strongly suggest that the N-tail is translocated into the
lumen in a C-to-N-terminal direction, starting with the insertion of
TM1 into the translocation apparatus. Interestingly, the rate of N-tail
translocation estimated from this experiment is quite slow and roughly
of the same order as the rate of chain elongation.
In this paper, we have analyzed the insertion of the E. coli inner membrane protein ProW into ER-derived microsomal
membranes. In E. coli, the 100-residues long ProW N-tail is
efficiently translocated across the inner membrane in the TM1-3/P2
construct, whereas in the shorter TM1/P2 construct it is translocated
in about 50% of the molecules (6). The lack of positively charged
residues immediately downstream of TM1 has been shown to be at least
partly responsible for the appearance of TM1/P2 molecules with an
inverted Ncyt-Cexo topology (7, 13).
The most unexpected finding in the present work is that very little
N-tail translocation across the microsomal membrane is seen unless a
minimum of four TM segments from ProW are present (Fig.
8). Instead, an inverted topology with
the N-tail on the cytoplasmic side of the membrane dominates for the
TM1, TM1-2, and TM1-3 constructs as determined by the glycosylation
status of the N-tail and two different C-terminal reporter domains.
Only when a minimum of four TM segments are present do we find a
significant fraction of molecules with the N-tail in the lumen. It thus
appears that the whole TM1-TM4 region has a direct influence on the
translocation of the N-tail. In general, the length of the C-terminal
tail does not influence N-tail translocation, except for the TM1-4
constructs where the N-tail is more efficiently translocated in the
*TM1-4/P2' fusion than when the protein is truncated after TM4.
Because in the truncated *TM1-4 construct TM4 is still inside the
ribosome when chain termination happens, it may not be able to
influence the overall topology of the molecule in this case.
Insertion of three positively charged residues in the TM1-TM2 loop
partially induces a topology with the TM1-TM2 loop in the cytoplasm and
the TM2-TM3 loop in the lumen but does not lead to translocation of the
N-tail unless it is shortened to 75 residues or less (Fig.
5A). Even without the extra positively charged residues in
the TM1-2 loop, shortening the N-tail to ~30 residues leads to
efficient N-tail translocation for all constructs with three or more TM
domains. Finally, when the ProW N-tail is fused to another E. coli inner membrane protein (Lep) with only two TM segments, it is
quite efficiently translocated.
Taken together, these results show that the balance between the
Ncyt and Nexo orientations of the N-tail can be
affected by sequence determinants more than 100 residues downstream of
the tail itself (i.e. TM4 in ProW). This suggests that the
final "decision" of whether or not to translocate the N-tail can be
influenced by the topological preferences of TM segments that have not
even been synthesized when TM1 enters the ER translocon, because only ~40 residues are required to span the distance between the translocon and the ribosomal P-site (35). Two extreme models for how this could
happen are that the more N-terminal TM segments initially integrate
into the ER membrane with the N-tail in the cytoplasm and are then
pulled back into the translocon where they reorient as the more
C-terminal TMs appear or that the whole protein remains in an
"undecided" state inside the translocon until at least four TM
segments have been made. At present, we cannot say which of the two
models is closer to the truth, because experimental data in favor of
both have been reported in the literature (4, 36-40). It is of course
also possible or even likely that different proteins make the
"topological decision" at different times during their biosynthesis, as suggested by the rather efficient N-tail translocation observed for the *Nt/Lep-P2' construct and for the ProW constructs with
shortened N-tails.
Finally, analysis of the glycosylation kinetics of two *Nt/Lep-P2'
constructs with glycosylation sites placed either N- or C-terminally in
the N-tail has allowed us to address a long standing question, namely
whether N-tail translocation proceeds in an N-to-C-terminal or
C-to-N-terminal direction. The results strongly suggest the latter and
further imply that the rate of N-tail translocation is of the same
order as the rate of chain elongation, at least in our in
vitro system.
Dog pancreas microsomes were a kind gift from
Dr. M. Sakaguchi.
*
This work was supported by grants from the Swedish Natural
and Technical Sciences Research Councils, the Swedish Cancer
Foundation, and the Göran Gustafsson Foundation and by European
Commission Grant BIO4-CT96-0129 (to G. v. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Inst. of Microbiology, University of Hohenheim,
Garbenstrasse 30, D-70599 Stuttgart, Germany.
¶
Present address: Dept. of Biochemistry, University of
Valencia, Dr. Moliner 50, E-46100 Burjossot, Valencia, Spain.
2
W. Mothes, personal communication.
3
I. Nilsson and G. von Heijne, unpublished data.
The abbreviations used are:
TM, transmembrane
segment;
Lep, leader peptidase;
PCR, polymerase chain reaction.
Distant Downstream Sequence Determinants Can Control N-tail
Translocation during Protein Insertion into the Endoplasmic
Reticulum Membrane*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 1.
Topology of ProW in E. coli
(6, 18). The positions of all P2, P2', and C* fusions and
C-terminal truncations are indicated (when two numbers are given, the
first is for the P2 and P2' fusions). The position of the three-Arg
insertion (3R) in the TM1-2 loop and the number of
positively charged residues (Arg+Lys) in the different loops are also
shown.

View larger version (41K):
[in a new window]
Fig. 2.
Localization of the N and C termini of
full-length ProW relative to the microsomal membrane. *ProW
(lanes 1 and 2), ProW/C* (lanes 3 and
4), and ProW/P2* (lanes 5 and 6)
(asterisk indicates the location of a unique glycosylation
site in the relevant domain) were expressed in vitro in the
absence (
) and presence (+) of rough dog pancreas microsomes
(RM). Nonglycosylated and glycosylated forms are indicated
by white and black dots, respectively.

View larger version (21K):
[in a new window]
Fig. 3.
Topology mapping of truncated ProW
constructs. A, degree of glycosylation of the P2* and
C* C-terminal reporter domains in ProW/P2* fusions (black
bars) and ProW/C* fusions (white bars). B,
alkaline extraction of ProW/P2* fusions. Constructs were expressed
in vitro in the absence (
) and presence (+) of rough
microsomes (RM), and the microsomes were subjected to
alkaline extraction (AE) before loading onto the gel.
Lanes 1-3, TM1-2/P2*; lanes 4-6, TM1-3/P2*.
Nonglycosylated and glycosylated forms are indicated by
white and black dots, respectively. C,
degree of glycosylation of the N-tail in *ProW/P2' fusions (black
bars) and C-terminally truncated *ProW constructs (white
bars).

View larger version (44K):
[in a new window]
Fig. 4.
Addition of three Arg residues to the TM1-2
loop enhances its retention in the cytoplasm. A, constructs
*TM1-2(3R)/P2' (lanes 1 and 2), TM1-2(3R)/P2*
(lanes 3 and 4), *TM1-3(3R)/P2' (lanes
5 and 6), and TM1-3(3R)/P2* (lanes 7 and
8) were expressed in vitro in the absence (
)
and presence (+) of rough microsomes (RM). Nonglycosylated
and glycosylated forms are indicated by white and
black dots, respectively. B, topology models for
the TM1-2(3R)/P2 (left) and TM1-3(3R)/P2
(right) constructs. Solid Y-shaped symbol,
glycosylated site; outlined Y-shaped symbol, nonglycosylated
site.

View larger version (16K):
[in a new window]
Fig. 5.
Shorter N-tails are more efficiently
translocated. A, degree of glycosylation of the N-tail
in *TM1/P2' (black circles), *TM1-2/P2' (white
circles), *TM1-3/P2' (white squares), and
*TM1-3(3R)/P2' (black squares) as a function of the number
of residues in the N-tail. B, degree of glycosylation of the
N-tail in *ProW(
1-70)/P2' constructs (black bars) and
C-terminally truncated *ProW constructs (white bars).
1-70), *TM1-2(
1-70), and *TM1-3(
1-70) truncations
were too poorly expressed to be analyzed).
1-70)/P2'-constructs is predominantly located in the lumen
already when only three TM domains are present, in contrast to the
full-length N-tail where four TM domains are required for significant
translocation of the N-tail (Fig. 3C).

View larger version (28K):
[in a new window]
Fig. 6.
Efficient translocation of the ProW N-tail
when fused to the N terminus of Lep. A, the Nt/Lep
fusion proteins (solid Y-shaped symbol, glycosylated site).
B, the *Nt/Lep-P2' (lane 1) and Nt/Lep-P2*
(lane 2) fusions were expressed in vitro in the
presence of rough microsomes (RM). Nonglycosylated and
glycosylated forms are indicated by white and black
dots, respectively.

View larger version (29K):
[in a new window]
Fig. 7.
The ProW N-tail is translocated in a
C-to-N-terminal direction. The *Nt(Asn5)/Lep-P2' and
*Nt(Asn80)/Lep-P2' constructs were expressed in
vitro in the presence of microsomes. After a 1.5-min incubation,
aurintricarboxylic acid was added to block further initiation. Samples
were removed at different time points, and Triton X-100 was added to
dissolve the microsomes and block further glycosylation. Translation
was then allowed to continue up to a total time of 60 min.
A, selected time points of Triton X-100 addition for
*Nt(Asn5)/Lep-P2' (top) and
*Nt(Asn80)/Lep-P2' (bottom). Nonglycosylated and
glycosylated forms are indicated by white and black
dots, respectively. B, kinetics of glycosylation
determined from two independent experiments for each construct.
White dots, *Nt(Asn5)/Lep-P2'; black
dots, *Nt(Asn80)/Lep-P2'). Mean values are shown by
crosses.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 8.
Topology models for the TM1/P2, TM1-2/P2,
and TM1-3/P2 fusions (top) and for full-length ProW
(bottom) inserted into microsomal membranes.
Solid Y-shaped symbol, glycosylated site; outlined
Y-shaped symbol, nonglycosylated site. The number of positively
charged residues (Arg+Lys) in the different loops are shown.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
These authors contributed equally to this work.
To whom correspondence should be addressed. Tel.:
46-8-16-25-90; Fax: 46-8-15-36-79; E-mail: gunnar@biokemi.su.se.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Blobel, G.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1496-1500 2.
Gafvelin, G.,
Sakaguchi, M.,
Andersson, H.,
and von Heijne, G.
(1997)
J. Biol. Chem.
272,
6119-6127 3.
Zhang, J.-T.,
Chen, M.,
Han, E.,
and Wang, C.
(1998)
Mol. Biol. Cell
9,
853-863 4.
Hegde, R. S.,
and Lingappa, V. R.
(1999)
Trends Cell Biol.
9,
132-137[CrossRef][Medline]
[Order article via Infotrieve]
5.
Dalbey, R. D.,
Kuhn, A.,
and von Heijne, G.
(1995)
Trends Cell Biol.
5,
380-383[CrossRef][Medline]
[Order article via Infotrieve]
6.
Whitley, P.,
Zander, T.,
Ehrmann, M.,
Haardt, M.,
Bremer, E.,
and von Heijne, G.
(1994)
EMBO J.
13,
4653-4661[Medline]
[Order article via Infotrieve]
7.
Whitley, P.,
Gafvelin, G.,
and von Heijne, G.
(1995)
J. Biol. Chem.
270,
29831-29835 8.
Cao, G. Q.,
and Dalbey, R. E.
(1994)
EMBO J.
13,
4662-4669[Medline]
[Order article via Infotrieve]
9.
Mitsopoulos, C.,
Hashemzadeh-Bonehi, L.,
and Broome-Smith, J.
(1997)
FEBS Lett
419,
18-22[CrossRef][Medline]
[Order article via Infotrieve]
10.
McMurry, J. L.,
and Kendall, D. A.
(1999)
J. Biol. Chem.
274,
6776-6782 11.
Oliver, J.,
Jungnickel, B.,
Görlich, D.,
Rapoport, T.,
and High, S.
(1995)
FEBS Lett.
362,
126-130[CrossRef][Medline]
[Order article via Infotrieve]
12.
Denzer, A. J.,
Nabholz, C. E.,
and Spiess, M.
(1995)
EMBO J.
14,
6311-6317[Medline]
[Order article via Infotrieve]
13.
Cristobal, S.,
Scotti, P.,
Luirink, J.,
von Heijne, G.,
and de Gier, J. W. L.
(1999)
J. Biol. Chem.
274,
20068-20070 14.
Wallin, E.,
and von Heijne, G.
(1995)
Protein Eng.
8,
693-698 15.
Delgado-Partin, V. M.,
and Dalbey, R. E.
(1998)
J. Biol. Chem.
273,
9927-9934 16.
Hartmann, E.,
Rapoport, T. A.,
and Lodish, H. F.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
5786-57890 17.
Monné, M.,
Gafvelin, G.,
Nilsson, R.,
and von Heijne, G.
(1999)
Eur. J. Biochem.
263,
264-269[Medline]
[Order article via Infotrieve]
18.
Haardt, M.,
and Bremer, E.
(1996)
J. Bacteriol.
178,
5370-5381 19.
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492 20.
Geisselsoder, J.,
Witney, F.,
and Yuckenberg, P.
(1987)
BioTechniques
5,
786-791
21.
Johnston, S.,
Lee, J. H.,
and Ray, D. S.
(1985)
Gene (Amst.)
34,
137-145[CrossRef][Medline]
[Order article via Infotrieve]
22.
Kozak, M.
(1992)
Annu. Rev. Cell Biol.
8,
197-225[CrossRef]
23.
Whitley, P.,
Nilsson, I.,
and von Heijne, G.
(1994)
Nat. Struct. Biol.
1,
858-862[CrossRef][Medline]
[Order article via Infotrieve]
24.
Liljeström, P.,
and Garoff, H.
(1991)
J. Virol.
65,
147-154 25.
Sakaguchi, M.,
Mihara, K.,
and Sato, R.
(1987)
EMBO J.
6,
2425-2431[Medline]
[Order article via Infotrieve]
26.
Lyman, S.,
and Schekman, R.
(1997)
Cell
88,
85-96[CrossRef][Medline]
[Order article via Infotrieve]
27.
van Geest, M.,
Nilsson, I.,
von Heijne, G.,
and Lolkema, J. S.
(1999)
J. Biol. Chem.
274,
2816-2823 28.
Nakai, T.,
Yamasaki, A.,
Sakaguchi, M.,
Kosaka, K.,
Mihara, K.,
Amaya, Y.,
and Miura, S.
(1999)
J. Biol. Chem.
274,
23647-23658 29.
Shakin-Eshleman, S. H.,
Wunner, W. H.,
and Spitalnik, S. L.
(1993)
Biochemistry
32,
9465-9472[CrossRef][Medline]
[Order article via Infotrieve]
30.
Fujiki, Y.,
Hubbard, A. L.,
Fowler, S.,
and Lazarow, P. B.
(1982)
J. Cell Biol.
93,
97-102 31.
Johansson, M.,
Nilsson, I.,
and von Heijne, G.
(1993)
Mol. Gen. Genet.
239,
251-256[CrossRef][Medline]
[Order article via Infotrieve]
32.
Nilsson, I.,
and von Heijne, G.
(1993)
J. Biol. Chem.
268,
5798-5801 33.
Rothman, J.,
and Lodish, H.
(1977)
Nature
269,
775-780[CrossRef][Medline]
[Order article via Infotrieve]
34.
Whitley, P.,
Nilsson, I. M.,
and von Heijne, G.
(1996)
J. Biol. Chem.
271,
6241-6244 35.
Mothes, W.,
Prehn, S.,
and Rapoport, T. A.
(1994)
EMBO J.
13,
3937-3982
36.
Mothes, W.,
Heinrich, S.,
Graf, R.,
Nilsson, I.,
von Heijne, G.,
Brunner, J.,
and Rapoport, T.
(1997)
Cell
89,
523-533[CrossRef][Medline]
[Order article via Infotrieve]
37.
Do, H.,
Falcone, D.,
Lin, J.,
Andrews, D. W.,
and Johnson, A. E.
(1996)
Cell
85,
369-378[CrossRef][Medline]
[Order article via Infotrieve]
38.
Borel, A. C.,
and Simon, S. M.
(1996)
Cell
85,
379-389[CrossRef][Medline]
[Order article via Infotrieve]
39.
Ota, K.,
Sakaguchi, M.,
von Heijne, G.,
Hamasaki, N.,
and Mihara, K.
(1998)
Mol. Cell
2,
495-503[CrossRef][Medline]
[Order article via Infotrieve]
40.
Goder, V.,
Bieri, C.,
and Spiess, M.
(1999)
J. Cell Biol.
147,
257-266
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. P. Morrow, S. I. Zakharov, G. Liu, L. Yang, A. J. Sok, and S. O. Marx Defining the BK channel domains required for beta1-subunit modulation PNAS, March 28, 2006; 103(13): 5096 - 5101. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Dewji, D. Valdez, and S. J. Singer From the Cover: The presenilins turned inside out: Implications for their structures and functions PNAS, January 27, 2004; 101(4): 1057 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Andersson, A. M. D'Antona, D. A. Kendall, G. Von Heijne, and C.-N. Chin Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail Mol. Pharmacol., September 1, 2003; 64(3): 570 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oertle, M. E. van der Haar, C. E. Bandtlow, A. Robeva, P. Burfeind, A. Buss, A. B. Huber, M. Simonen, L. Schnell, C. Brosamle, et al. Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions J. Neurosci., July 2, 2003; 23(13): 5393 - 5406. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, Q. Yan, G. von Heijne, G. A. Caputo, and W. J. Lennarz Determination of the membrane topology of Ost4p and its subunit interactions in the oligosaccharyltransferase complex in Saccharomyces cerevisiae PNAS, June 24, 2003; 100(13): 7460 - 7464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vilar, A. Sauri, M. Monne, J. F. Marcos, G. von Heijne, E. Perez-Paya, and I. Mingarro Insertion and Topology of a Plant Viral Movement Protein in the Endoplasmic Reticulum Membrane J. Biol. Chem., June 21, 2002; 277(26): 23447 - 23452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dohke and R. J. Turner Evidence That the Transmembrane Biogenesis of Aquaporin 1 Is Cotranslational in Intact Mammalian Cells J. Biol. Chem., April 19, 2002; 277(17): 15215 - 15219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Abell, S. High, and M. M. Moloney Membrane Protein Topology of Oleosin Is Constrained by Its Long Hydrophobic Domain J. Biol. Chem., March 1, 2002; 277(10): 8602 - 8610. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. El Meskini, L. Jin, R. Marx, A. Bruzzaniti, J. Lee, R. B. Emeson, and R. E. Mains A Signal Sequence Is Sufficient for Green Fluorescent Protein to Be Routed to Regulated Secretory Granules Endocrinology, February 1, 2001; 142(2): 864 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nilsson and G. von Heijne Glycosylation Efficiency of Asn-Xaa-Thr Sequons Depends Both on the Distance from the C Terminus and on the Presence of a Downstream Transmembrane Segment J. Biol. Chem., June 2, 2000; 275(23): 17338 - 17343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lewis, L. L. Listenberger, D. S. Ory, and J. E. Schaffer Membrane Topology of the Murine Fatty Acid Transport Protein 1 J. Biol. Chem., September 28, 2001; 276(40): 37042 - 37050. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||